3 Best-performing Canadian Pharma Stocks of 2024

From established players to up-and-coming firms, Canada’s pharmaceutical company is diverse and dynamic. Canadian pharma companies are working to discover and develop major

Proposed Consolidation of Capital

Labyrinth Resources Limited (‘the Company’ or ‘Labyrinth’) advises that it is seeking shareholder approval at the upcoming Extraordinary General Meeting of Shareholders